NYSE$YCBD

cbdMD Inc · Q1 2025 earnings

Q1 2025 earnings · · After market close · Investor relations

Briefing

cbdMD reported a decrease in net sales but achieved positive net income and EBITDA, driven by strategic changes and growth in wholesale sales and new beverage line.

cbdMD reported total net sales of $5.1 million for the three months ended December 31, 2024, a decrease of 4.9% year-over-year. Despite the sales decline, the company achieved a net income of $15,095 and positive Adjusted EBITDA of $214,817. This performance was attributed to optimizing product portfolio, right-sizing cost structure, and investing in marketing, with wholesale sales showing a positive impact and the launch of a new beverage line.

  • Total net sales decreased by 4.9% year-over-year to $5.1 million, primarily due to a reduction in e-commerce sales.
  • The company achieved a net income of $15,095 for the quarter, a significant improvement from a net loss in the prior year.
  • Adjusted EBITDA was positive at $214,817, reflecting the company's focus on profitability and cost controls.
  • Wholesale sales increased by $0.2 million year-over-year, partially offsetting the decline in e-commerce sales.

Headline financials

Total Revenue

$5.11M

Previous: $5.38M-4.9%
EPS

-$0.22

Previous: -$0.67+67.2%
Adjusted EBITDA

$215K

No prior period
Gross profit margin

66.5%

No prior period
Operating expenses

$3.49M

No prior period
Capital Expenditures

-$164K

Previous: -$185K+11.0%
Free Cash Flow

-$149K

Previous: -$1.18M+87.4%
Net Income

$15.1K

Previous: -$997K+101.5%
Operating Income

-$86.3K

Previous: -$1.07M+91.9%
Gross Profit

$3.4M

Previous: $3.56M-4.4%
Cash & Equivalents

$1.97M

Previous: $1.5M+30.9%
Total Assets

$11.5M

Previous: $15.1M-23.5%

Revenue & EPS history

cbdMD · Revenue · Quarterly

$5.11M

Q1 2025-4.9%vs Q1 2024
Beat estimate in 2 of 14 quarters(14%)
ActualEstimate

Revenue by segment

cbdMD · $3.8M total across 1 segment · Q2 2026

  • E-commerce sales
    $3.8M

Forward guidance

cbdMD is focused on achieving profitability and expanding its business in fiscal 2025 and beyond through product innovation, channel expansion, and brand cultivation. The company aims to improve profitability and cash flow, with a focus on cost controls and strategic growth initiatives.

Tailwinds

  • Continued focus on optimizing product portfolio and right-sizing cost structure to drive positive earnings.
  • Launch of new hemp-derived, ready-to-drink beverages under the Herbal Oasis line, targeting a fast-growing category.
  • Ongoing research and development to enhance product effectiveness and improve taste, with a pipeline of new products and formulation upgrades.
  • Expanding revenue channels through relationships with traditional retail accounts and distributors, including Door Dash and GNC.
  • Continued international expansion, particularly in the UK via Amazon and gaining market share in Central and South America.

Headwinds

  • Overall category facing challenges, despite the company's optimistic market positioning.
  • Larger cost-saving opportunities are harder to identify and implement after significant progress in 2023 and 2024.
  • Anticipated increases in marketing expenses in future quarters.
  • Working capital position may not be sufficient to support daily operations for the next twelve months.
  • Current capital structure, specifically the overhang of Series A Preferred stock, has stalled potential accretive acquisitions.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2025

Historical avgQ1 2025

-0.5%

Avg return

Earnings day

-3.1%

Avg return

5 days after

-10.8%

Avg return

30 days after

42%

15 / 36 earnings

Positive

+70.1%

Q2 2020

Best reaction

-22.4%

Q4 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2025+0.0%+5.3%-38.9%
Q3 2025-11.1%-22.4%-20.0%
Q2 2026-4.0%-8.2%-13.2%
Q2 2025-4.0%-8.2%-13.2%
Q1 2025-15.1%-24.6%-52.6%
Q4 2024-15.7%-22.1%+14.4%
Q3 2024+3.7%+2.1%+7.6%
Q2 2024+0.0%+1.0%-8.6%
Q1 2024-12.3%-5.5%-0.7%
Q4 2023+7.9%+6.4%+17.7%
Q3 2023+0.7%-5.6%-9.8%
Q2 2023-6.9%-6.0%-21.6%
Q1 2023-5.8%+1.8%-28.1%
Q4 2022-22.4%-29.9%-8.6%
Q3 2022-5.9%-11.6%-48.4%
Q2 2022+8.4%+28.6%-31.7%
Q1 2022-19.5%-16.3%-14.0%
Q4 2021+3.5%+0.9%-7.1%
Q3 2021-5.0%-7.8%+3.7%
Q2 2021-21.8%-17.4%-0.3%
Q1 2021+15.2%-9.2%-19.4%
Q4 2020+15.1%+6.5%+6.5%
Q3 2020+8.1%+10.2%-27.6%
Q2 2020+70.1%+71.1%+54.6%
Q1 2020+2.6%+0.0%-40.9%
Q4 2019-0.7%-1.4%-59.7%
Q3 2019-9.4%-11.6%-11.4%
Q2 2019-3.1%+0.6%-2.0%
Q1 2019+1.8%+6.5%-9.7%
Q4 2018-12.4%-21.1%+7.2%
Q3 2017+14.4%+1.4%+13.0%
Q3 2018+14.4%+1.4%+13.0%
Q2 2017-1.2%-10.2%-22.3%
Q2 2018-1.2%-10.2%-22.3%
Q1 2018-7.7%-10.1%-14.3%
Q4 2017+2.9%+5.3%+18.6%
Q1 2017
Q4 2016
Q3 2016

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro